{
  "url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-regulations-2005/regulation-25",
  "json_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-regulations-2005/regulation-25.json",
  "legislation": "uksi/2005/641",
  "legislation_title": "The National Health Service (Pharmaceutical Services) Regulations 2005",
  "legislation_url": "https://openlegislation.uk/national-health-service-pharmaceutical-services-regulations-2005",
  "path": "regulation/25",
  "kind": "regulation",
  "number": "25",
  "heading": "Deferral of consideration of certain applications",
  "text": "(1) Subject to paragraph (2), this regulation applies to—\n(a) an application under regulation 5(1);\n(b) such an application where the applicant has previously been granted preliminary consent, but where regulation 41(2) applies;\n(c) an application for preliminary consent under regulation 40; or\n(d) a notification under regulation 39(8),\nrelating to the provision of pharmaceutical services from premises or, in the case of a notification under sub-paragraph (d) above, the changed premises which are specified or described in a designation, or located within a neighbourhood specified in a designation.\n(2) This regulation does not apply to—\n(a) an application under regulation 5(1) and to which regulation 8, 9 or 10 applies;\n(b) an application under regulation 5(1) where the applicant has previously been granted preliminary consent, and where all the conditions specified in regulation 41(1) are satisfied;\n(c) an application under regulation 40 and to which, by virtue of regulation 40(3), regulation 8 or 9 applies;\n(d) an application or notification in respect of which a determination by the Primary Care Trust has been made, where that determination is the subject of an appeal under regulation 29 or 38; or\n(e) an application or notification which was received by the Primary Care Trust more than 30 days before the date of the designation mentioned in paragraph (1).\n(3) A Primary Care Trust may defer consideration or determination of an application or notification to which this regulation applies; but, subject to any power to defer contained in regulation 26, may no longer do so when the designation mentioned in paragraph (1) is cancelled, or varied in such a way that it no longer specifies or includes the premises in question.\n(4) A Primary Care Trust must, as soon as is practicable, notify the applicant of a decision to defer consideration or determination of his application or notification, and send him a copy of the designation mentioned in paragraph (1).\n(5) In this regulation, “designation” means a designation made by a Primary Care Trust under regulation 3(1) of the National Health Service (Local Pharmaceutical Services and Pharmaceutical Services) Regulations 2002.",
  "extent": null,
  "status": null,
  "version": "current",
  "annotations": [
    {
      "type": "footnote",
      "label": "f1",
      "text": "S.I. 2002/888."
    }
  ],
  "outstanding_effects": [
    {
      "type": "am",
      "affecting": "uksi/2009/599",
      "affecting_title": "The National Health Service (Pharmaceutical Services and Local Pharmaceutical Services) Amendment Regulations 2009"
    }
  ],
  "provenance": {
    "source": "legislation.gov.uk",
    "source_url": "https://www.legislation.gov.uk/uksi/2005/641/regulation/25",
    "retrieved_at": "2026-10-29T05:04:38.912950+00:00"
  },
  "licence": "Open Government Licence v3.0",
  "licence_url": "https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/",
  "attribution": "Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives."
}